Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 68 | 2024 | 6901 | 3.930 |
Why?
|
Carcinoma, Pancreatic Ductal | 19 | 2024 | 1726 | 2.100 |
Why?
|
Pancreatic Neoplasms | 31 | 2024 | 5363 | 2.000 |
Why?
|
Tumor Microenvironment | 27 | 2024 | 3873 | 1.620 |
Why?
|
Microsatellite Instability | 26 | 2024 | 715 | 1.560 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 15 | 2024 | 1089 | 1.500 |
Why?
|
Adenocarcinoma | 17 | 2024 | 6332 | 1.370 |
Why?
|
DNA Mismatch Repair | 9 | 2024 | 428 | 1.220 |
Why?
|
Fusobacterium nucleatum | 9 | 2021 | 179 | 1.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 8 | 2024 | 898 | 0.900 |
Why?
|
Colonic Neoplasms | 8 | 2024 | 2534 | 0.840 |
Why?
|
Proto-Oncogene Proteins B-raf | 16 | 2024 | 2052 | 0.810 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2024 | 321 | 0.800 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 13 | 2024 | 1742 | 0.740 |
Why?
|
Mutation | 40 | 2024 | 30044 | 0.730 |
Why?
|
Genes, erbB-2 | 1 | 2020 | 162 | 0.680 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2019 | 380 | 0.670 |
Why?
|
Granulocytes | 1 | 2021 | 552 | 0.650 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 322 | 0.620 |
Why?
|
CpG Islands | 7 | 2024 | 1225 | 0.590 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 378 | 0.590 |
Why?
|
DNA Mutational Analysis | 7 | 2024 | 4108 | 0.590 |
Why?
|
Pathology, Molecular | 5 | 2024 | 328 | 0.590 |
Why?
|
Prognosis | 29 | 2024 | 29588 | 0.530 |
Why?
|
DNA Methylation | 16 | 2024 | 4383 | 0.510 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2023 | 3638 | 0.470 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 611 | 0.420 |
Why?
|
Cell Lineage | 2 | 2020 | 2556 | 0.390 |
Why?
|
Monocytes | 1 | 2021 | 2573 | 0.380 |
Why?
|
Neoplasm Staging | 5 | 2024 | 11098 | 0.380 |
Why?
|
Prospective Studies | 34 | 2024 | 54405 | 0.370 |
Why?
|
DNA, Bacterial | 5 | 2018 | 1481 | 0.350 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2811 | 0.340 |
Why?
|
Humans | 131 | 2024 | 761326 | 0.340 |
Why?
|
Hair Follicle | 2 | 2009 | 211 | 0.330 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.330 |
Why?
|
Diet | 9 | 2024 | 8074 | 0.320 |
Why?
|
Aged | 60 | 2024 | 169179 | 0.300 |
Why?
|
Myeloid Cells | 3 | 2024 | 823 | 0.290 |
Why?
|
Helicobacter pylori | 2 | 2023 | 377 | 0.280 |
Why?
|
Cyclooxygenase 2 | 3 | 2020 | 597 | 0.280 |
Why?
|
Stem Cells | 3 | 2009 | 3521 | 0.280 |
Why?
|
Middle Aged | 61 | 2024 | 220774 | 0.280 |
Why?
|
Immunotherapy | 5 | 2024 | 4649 | 0.280 |
Why?
|
Neoplasms | 9 | 2024 | 22158 | 0.270 |
Why?
|
Germ-Line Mutation | 7 | 2024 | 1858 | 0.260 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2017 | 318 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2024 | 4576 | 0.260 |
Why?
|
Calcium, Dietary | 2 | 2019 | 529 | 0.250 |
Why?
|
Neoadjuvant Therapy | 4 | 2024 | 2823 | 0.250 |
Why?
|
Male | 68 | 2024 | 360621 | 0.250 |
Why?
|
Tumor Escape | 2 | 2018 | 370 | 0.240 |
Why?
|
Female | 71 | 2024 | 392485 | 0.240 |
Why?
|
Carcinoma | 4 | 2017 | 2328 | 0.240 |
Why?
|
Arginase | 1 | 2024 | 80 | 0.220 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39108 | 0.220 |
Why?
|
Phenotype | 11 | 2024 | 16603 | 0.220 |
Why?
|
Deoxycytidine | 2 | 2024 | 875 | 0.220 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 117 | 0.210 |
Why?
|
Proportional Hazards Models | 12 | 2022 | 12450 | 0.210 |
Why?
|
Cell Separation | 1 | 2009 | 1722 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11735 | 0.210 |
Why?
|
Disease-Free Survival | 6 | 2024 | 6815 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 8 | 2024 | 6473 | 0.210 |
Why?
|
Leucovorin | 1 | 2024 | 642 | 0.210 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 631 | 0.210 |
Why?
|
Rectal Neoplasms | 3 | 2016 | 1157 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1805 | 0.200 |
Why?
|
Bacteroides fragilis | 1 | 2024 | 252 | 0.200 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 83 | 0.200 |
Why?
|
Leukocytes | 2 | 2021 | 2029 | 0.200 |
Why?
|
Metalloendopeptidases | 1 | 2024 | 393 | 0.200 |
Why?
|
Epithelial Cells | 3 | 2009 | 3666 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 4 | 2023 | 4509 | 0.200 |
Why?
|
Helicobacter Infections | 2 | 2023 | 386 | 0.200 |
Why?
|
Keloid | 1 | 2022 | 54 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 124 | 0.190 |
Why?
|
Staining and Labeling | 2 | 2020 | 1085 | 0.190 |
Why?
|
Long Interspersed Nucleotide Elements | 3 | 2020 | 330 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2610 | 0.180 |
Why?
|
Alkylating Agents | 1 | 2021 | 133 | 0.180 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10191 | 0.180 |
Why?
|
Weight Loss | 2 | 2024 | 2683 | 0.180 |
Why?
|
Colitis | 2 | 2020 | 1231 | 0.180 |
Why?
|
Hematoxylin | 1 | 2020 | 60 | 0.180 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 69 | 0.180 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2004 | 540 | 0.180 |
Why?
|
Survival Analysis | 8 | 2020 | 10075 | 0.180 |
Why?
|
Paclitaxel | 2 | 2024 | 1732 | 0.170 |
Why?
|
Autophagy | 3 | 2022 | 1321 | 0.170 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2021 | 218 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9275 | 0.170 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2468 | 0.170 |
Why?
|
Receptors, Chemokine | 2 | 2020 | 653 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 214 | 0.170 |
Why?
|
Adult | 38 | 2024 | 221122 | 0.170 |
Why?
|
Fluorouracil | 1 | 2024 | 1637 | 0.170 |
Why?
|
Lymphocyte Count | 5 | 2022 | 778 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 311 | 0.160 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.160 |
Why?
|
Paraffin Embedding | 1 | 2020 | 302 | 0.160 |
Why?
|
Lysine | 1 | 2023 | 991 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.160 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11070 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2024 | 8527 | 0.160 |
Why?
|
Microsatellite Repeats | 2 | 2021 | 785 | 0.160 |
Why?
|
Interleukin-1beta | 1 | 2024 | 997 | 0.160 |
Why?
|
Formaldehyde | 1 | 2020 | 358 | 0.150 |
Why?
|
Intestine, Small | 2 | 2021 | 1205 | 0.150 |
Why?
|
Sarcoma | 2 | 2020 | 1793 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 523 | 0.150 |
Why?
|
Bifidobacterium | 1 | 2018 | 97 | 0.150 |
Why?
|
Ribonuclease III | 1 | 2020 | 278 | 0.150 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 82 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 553 | 0.150 |
Why?
|
Forkhead Transcription Factors | 3 | 2020 | 1612 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2020 | 552 | 0.140 |
Why?
|
Colon | 3 | 2020 | 1792 | 0.140 |
Why?
|
Folic Acid | 1 | 2024 | 1320 | 0.140 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.140 |
Why?
|
Coffee | 1 | 2022 | 593 | 0.140 |
Why?
|
Jews | 1 | 2019 | 364 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1405 | 0.140 |
Why?
|
DEAD-box RNA Helicases | 1 | 2020 | 383 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 896 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5297 | 0.140 |
Why?
|
Incidence | 12 | 2024 | 21336 | 0.140 |
Why?
|
Feeding Behavior | 2 | 2021 | 3187 | 0.140 |
Why?
|
United States | 13 | 2024 | 72317 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 245 | 0.130 |
Why?
|
Molecular Epidemiology | 4 | 2019 | 468 | 0.130 |
Why?
|
Lymph Nodes | 2 | 2017 | 3469 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2024 | 3512 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 552 | 0.130 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 605 | 0.130 |
Why?
|
Mullerian Ducts | 1 | 2016 | 203 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 642 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 773 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 953 | 0.120 |
Why?
|
Aspirin | 2 | 2017 | 3134 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.120 |
Why?
|
Pathology, Clinical | 2 | 2015 | 375 | 0.120 |
Why?
|
Germ Cells | 3 | 2024 | 634 | 0.120 |
Why?
|
Skin | 1 | 2008 | 4482 | 0.120 |
Why?
|
Gastric Mucosa | 1 | 1997 | 601 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3122 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 733 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 616 | 0.120 |
Why?
|
Body Composition | 1 | 2023 | 2422 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 194 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2648 | 0.110 |
Why?
|
Rectum | 2 | 2019 | 892 | 0.110 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 193 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1317 | 0.110 |
Why?
|
Utilization Review | 1 | 2015 | 382 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17872 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 616 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.110 |
Why?
|
Seafood | 1 | 2016 | 393 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1223 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 987 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3244 | 0.100 |
Why?
|
Cost Control | 1 | 2015 | 628 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2203 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4342 | 0.100 |
Why?
|
Up-Regulation | 2 | 2019 | 4120 | 0.100 |
Why?
|
Risk Factors | 15 | 2024 | 74152 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
Phagocytosis | 1 | 2017 | 1536 | 0.100 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 9414 | 0.100 |
Why?
|
Alcohol Drinking | 1 | 2024 | 4027 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1273 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2527 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 725 | 0.090 |
Why?
|
Genomics | 3 | 2024 | 5817 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2159 | 0.090 |
Why?
|
Macrophages | 3 | 2023 | 5768 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2020 | 810 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2273 | 0.080 |
Why?
|
MicroRNAs | 2 | 2016 | 3796 | 0.080 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 711 | 0.080 |
Why?
|
Integrin alpha6 | 1 | 2009 | 30 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2009 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1432 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58946 | 0.080 |
Why?
|
Mice | 11 | 2024 | 81474 | 0.080 |
Why?
|
Ubiquitins | 2 | 2000 | 366 | 0.080 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12059 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20092 | 0.080 |
Why?
|
Mitomycin | 1 | 2009 | 263 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2650 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3611 | 0.070 |
Why?
|
Computational Biology | 2 | 2017 | 3512 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6909 | 0.070 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 177 | 0.070 |
Why?
|
SOX9 Transcription Factor | 1 | 2008 | 145 | 0.070 |
Why?
|
Cohort Studies | 9 | 2021 | 41440 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1647 | 0.070 |
Why?
|
Skin Physiological Phenomena | 1 | 2008 | 188 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12449 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2020 | 18962 | 0.070 |
Why?
|
3T3 Cells | 1 | 2009 | 1084 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1392 | 0.070 |
Why?
|
Cannabinoids | 1 | 2009 | 172 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2009 | 658 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2020 | 5866 | 0.070 |
Why?
|
Obesity | 2 | 2020 | 12934 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.070 |
Why?
|
Body Mass Index | 3 | 2020 | 12949 | 0.060 |
Why?
|
Integrases | 1 | 2008 | 516 | 0.060 |
Why?
|
Calcium | 1 | 2019 | 5726 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2015 | 2909 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2332 | 0.060 |
Why?
|
Pancreas | 2 | 2024 | 1689 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5778 | 0.060 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2448 | 0.060 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 2020 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16966 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12666 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5665 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15262 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3200 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15879 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2859 | 0.060 |
Why?
|
Morphogenesis | 1 | 2008 | 741 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9180 | 0.060 |
Why?
|
Bacteroides Infections | 1 | 2024 | 89 | 0.060 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2004 | 84 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
Signal Transduction | 3 | 2024 | 23427 | 0.060 |
Why?
|
Animals | 11 | 2024 | 168388 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1133 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2024 | 2549 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6571 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2017 | 11531 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2421 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2004 | 282 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6389 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6595 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2022 | 61 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 117 | 0.050 |
Why?
|
Allosteric Regulation | 1 | 2023 | 426 | 0.050 |
Why?
|
Sulfur | 1 | 2022 | 162 | 0.050 |
Why?
|
Albumins | 1 | 2024 | 575 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Biological Availability | 1 | 2022 | 390 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 199 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 7954 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4321 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 454 | 0.050 |
Why?
|
Logistic Models | 3 | 2024 | 13251 | 0.050 |
Why?
|
Intention | 1 | 2024 | 347 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 180 | 0.050 |
Why?
|
Endocrine Cells | 1 | 2020 | 9 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 696 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2000 | 1841 | 0.040 |
Why?
|
DNA Repair | 2 | 2021 | 2044 | 0.040 |
Why?
|
Exocrine Glands | 1 | 2020 | 46 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 329 | 0.040 |
Why?
|
Cysteine Endopeptidases | 2 | 2000 | 551 | 0.040 |
Why?
|
Cell Cycle | 1 | 2008 | 2930 | 0.040 |
Why?
|
Vacuoles | 1 | 2000 | 228 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2821 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2023 | 569 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1598 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 597 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11116 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1342 | 0.040 |
Why?
|
Multienzyme Complexes | 2 | 2000 | 666 | 0.040 |
Why?
|
Fungal Proteins | 2 | 2000 | 910 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 238 | 0.040 |
Why?
|
beta Catenin | 2 | 2020 | 1040 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2000 | 2687 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4877 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2005 | 1753 | 0.040 |
Why?
|
Survival Rate | 3 | 2018 | 12710 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 197 | 0.040 |
Why?
|
Nurses | 2 | 2019 | 2478 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 103 | 0.040 |
Why?
|
Gene Amplification | 1 | 2023 | 1086 | 0.040 |
Why?
|
ras Proteins | 1 | 2023 | 1053 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 2024 | 932 | 0.040 |
Why?
|
Transcription Factors | 3 | 2022 | 12122 | 0.040 |
Why?
|
Urease | 1 | 1997 | 39 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15599 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9030 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
Histological Techniques | 1 | 1997 | 193 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 329 | 0.040 |
Why?
|
Health Personnel | 2 | 2024 | 3335 | 0.040 |
Why?
|
Wound Healing | 1 | 2008 | 2802 | 0.040 |
Why?
|
Multigene Family | 1 | 2020 | 1077 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 1997 | 330 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 59196 | 0.030 |
Why?
|
Endopeptidases | 1 | 2000 | 773 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1783 | 0.030 |
Why?
|
Proteins | 2 | 2009 | 6034 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2018 | 176 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4466 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4371 | 0.030 |
Why?
|
Endocytosis | 1 | 2000 | 958 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2009 | 10431 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6374 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 960 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2105 | 0.030 |
Why?
|
Problem Solving | 1 | 2018 | 441 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22124 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 662 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9605 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2858 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1114 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2017 | 14409 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 88305 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2803 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2488 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1125 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1897 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 1967 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2442 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
Glioma | 1 | 2009 | 3455 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 508 | 0.030 |
Why?
|
Esophagectomy | 1 | 2018 | 465 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1792 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4908 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 612 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3076 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2023 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2017 | 759 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 2911 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 6086 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 941 | 0.030 |
Why?
|
Smoking | 2 | 2022 | 9051 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4614 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2723 | 0.030 |
Why?
|
HLA Antigens | 1 | 2018 | 1371 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1008 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3025 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64645 | 0.030 |
Why?
|
Expert Testimony | 1 | 2015 | 363 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3588 | 0.020 |
Why?
|
Genotype | 2 | 2024 | 12982 | 0.020 |
Why?
|
Apoptosis | 3 | 2017 | 9474 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2017 | 1254 | 0.020 |
Why?
|
Gene Dosage | 1 | 2016 | 1218 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2024 | 3413 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3310 | 0.020 |
Why?
|
Epigenomics | 1 | 2017 | 941 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39974 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3969 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1486 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2321 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2603 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3082 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22154 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2019 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 80575 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1803 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4234 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1624 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3847 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2914 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2009 | 68 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1863 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2009 | 203 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5439 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12787 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2300 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13500 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 181 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4927 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42251 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 868 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2008 | 532 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23981 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 729 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3685 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1457 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3075 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5491 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2746 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6768 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3843 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7390 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8632 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2820 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 1075 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1674 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2000 | 1319 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9639 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1135 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1121 | 0.010 |
Why?
|
Child | 2 | 2021 | 80156 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11900 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14665 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3597 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3356 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4567 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3590 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18234 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10760 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2000 | 190 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2453 | 0.010 |
Why?
|
Intramolecular Transferases | 1 | 1999 | 14 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2060 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2385 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3777 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36202 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3161 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8997 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6178 | 0.010 |
Why?
|
Polyubiquitin | 1 | 1999 | 68 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 150 | 0.010 |
Why?
|
Biopolymers | 1 | 1999 | 184 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3710 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 13446 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2009 | 2985 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4246 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2870 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8312 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3448 | 0.010 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2000 | 455 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17640 | 0.010 |
Why?
|
Mutagenesis | 1 | 2000 | 1232 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1793 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2749 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2180 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20555 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21009 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14025 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26108 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36430 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9468 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6525 | 0.010 |
Why?
|